Financials

News Ideas Discussions Technicals Forecast Seasonals Options

RARE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Ultragenyx Pharmaceutical Inc.

Total assets of RARE for Q1 25 is 1.31 B USD, 12.74% less than the previous Q4 24. And total liabilities decreased by 6.48% in Q1 25 to 1.16 B USD.

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD